baber/WOPTO huggingface dataset:
Patent DE-60315951-T2 (DE)
Inventor: MOERNDAL STAFFAN
IPC: B60B33/00
Filed: 2003-02-14
Granted: 2008-05-15
Abstract: The present invention relates to an arrangement in a wheel lifting mechanism designed to lift at least one wheel ( 1 ) running on an underlying surface so that it is capable of negotiating an obstacle (h) rising above the underlying surface. The arrangement comprises an element ( 7 ) which is formed with a contour convexly curved towards the underlying surface and is moveably supported in relation to the axle of the wheel ( 1 ). The said element is designed, when the contour of the element ( 7 ) engages with the obstacle (h), to bring about the said lifting of the wheel ( 7 ) as the element ( 7 ) is rotated about its point of engagement with the obstacle (h). The arrangement further comprises a chassis ( 4 ), to which the wheel axle is firmly connected. Between the chassis and the element ( 7 ) there is an operative connection designed, when the element ( 7 ) engages with the obstacle (h), to allow the chassis ( 4 ) firstly to undertake lifting of the wheel ( 1 ) from a home position of the element ( 7 ) during a displacing movement relative thereto in the direction of movement of the wheel, and secondly to bring about a return to the home position once the wheel ( 1 ) has been lifted to the level of the obstacle (h).
Patent DE-60317545-T2 (DE)
Inventor: FILIPPI ERMANNO
IPC: C07C45/38
Filed: 2003-09-08
Granted: 2008-09-18
Abstract: Highly exothermic oxidizing reactions in pseudo-isothermal conditions involves feeding a part of reactants in continuous flow to a catalytic bed at different points of the catalytic bed corresponding to different successive stages of the reactions, at respective predetermined temperatures and flow rates. The catalytic bed has several heat exchangers (10), each of which is associated with at least one distribution-supplier (12) for continuous feeding. An independent claim is included for a reactor (1) including a shell (2) containing an apparatus immersed in a catalytic bed (L).
Patent DE-60317883-T2 (DE)
Inventor: BLANK THIEMO ARNIM
IPC: A61F2/82
Filed: 2003-03-14
Granted: 2008-11-13
Abstract: The present invention relates to tubular radially expansible metal structures, having an abluminal wall, a luminal wall and a radial wall thickness therebetween with struts defining through-apertures in the wall, the structure further defining a plurality of expansible rings arranged adjacent one another along the longitudinal axis of the structure, each of the rings defining at least one bridge strut, and adjacent rings being linked by a bridge extending between adjacent bridge struts on adjacent rings. The bridges, a plurality of which are distributed throughout the length of the tubular structure and are configured and arranged to divide the tubular structure into axially spaced and electrically insulated sections, advantageously exhibit reduced electrical conductivity throughout their wall thickness. The present invention relates furthermore to a method of manufacturing such a tubular structure, as well as a method of visualizing a bodily lumen supported by such a tubular structure deployed therein.
Patent DE-68901944-T2 (DE)
Inventor: DELLACHERIE EDITH
IPC: C08F8/00
Filed: 1989-04-18
Granted: 1992-12-10
Abstract: The invention relates to a method of preparation of water-soluble macromolecular conjugates of haemoglobin, wherein:
 - in a first step, sites Z are bound to a polymer P, the sites Z containing on the one hand at least one negative charge carried, for example, by sulphate groups and intended for creating an ionic bond with haemoglobin, and containing on the other hand at least ..... for example, by a carboxyl group and intended for creating a covalent bond with haemoglobin,
 - then, in a second step, the polymer P containing the site or sites Z is reacted with haemoglobin in oxygenated form, to form, on the one hand at least one ionic bond between at least one of the sites Z carried by the polymer and the haemoglobin, and on the other hand at least one covalent bond between the abovementioned same site Z carried by the polymer and the haemoglobin. 
<??>The macromolecular conjugates obtained by this method possess a lower affinity for oxygen than that of free haemoglobin.
Patent DE-68908506-T2 (DE)
Inventor: MCCULLOUGH FRANCIS P
IPC: C04B41/88
Filed: 1989-08-17
Granted: 1993-12-02
Abstract: A porous composite structure comprising a heat set porous ceramic composition and a carbonaceous fiber structure in a reinforcing amount.
Patent DE-68911395-T2 (DE)
Inventor: GRENNER GERD
IPC: B01L3/00
Filed: 1989-06-22
Granted: 1994-04-14
Abstract: There is described a device for providing a controlled flow of liquid in a liquid flow zone between two surfaces (16), (18) wherein one surface (16) includes a plurality of projections (22), or raised areas, arranged substantially throughout the surface in the liquid flow zone and an aperture (20) for allowing the introduction of liquid between the two surfaces. In a preferred embodiment the projections on the first surface are arranged in parallel spaced rows and parallel spaced columns. The second surface (18) may be one surface of a layer of a diagnostic assay element.
Patent DE-68915793-T2 (DE)
Inventor: CACABELOS RAMON AVENIDA DE LA
IPC: A61K49/00
Filed: 1989-01-26
Granted: 1995-03-09
Abstract: The mental functions of an individual are enhanced by the administration of a hypothalamic hypophsyiotropic hormone to that individual.
Patent DE-68924298-T2 (DE)
Inventor: INANAGA KIYOFUMI C O PATENTS D
IPC: H04R9/04
Filed: 1989-04-19
Granted: 1996-03-21
Abstract: A loudspeaker (21) comprises a diaphragm (22) having a vibrating portion (215) and an annular conductive portion (28), a current feeding coil (23) facing the conductive portion (28) with a predetermined magnetic gap, and a magnetic circuit (24, 25, 26, 211) comprising a top plate (24), a magnet (25) and a yoke plate (26) to which the current feeding coil (23) is attached. A capacitor which forms a high-pass filter together with the internal resistance of the current feeding coil (23) is connected serially with the current feeding coil (23). <IMAGE>
Patent DE-68925409-T2 (DE)
Inventor: BOLLE DAVID
IPC: H02J7/14
Filed: 1989-11-29
Granted: 1996-08-14
Abstract: A control arrangement (10) for an electrical charging system for selectively connecting alternator means (18) producing charging current at each of six outputs (22,26,30,22 min ,26 min ,30 min ) to the output of a first battery (34) and the output of a second battery (46) serially connected to the first battery (34), comprises a plurality of switchable full wave bridge rectifiers (78) for connecting each of the alternator outputs to the second battery output (50) so that the second battery (46) is charged. The rectifiers (78) are switchably connectible to the first battery output (38) so that the first battery (34) is charged. The arrangement also includes a switching circuit (74) for switching first one, and then the next of each of the switchable circuits as the voltage across the first battery (34) is increasingly less than the voltage across the second battery (46) so that the rate of charging of the first battery (34) is determined by the amount the voltage across the first battery (34) is less than the voltage across the second battery (46).
Patent DE-69005552-T2 (DE)
Inventor: JOHNSON CLAUDE
IPC: B64G1/10
Filed: 1990-07-16
Granted: 1994-06-23
Abstract: According to the invention, the capsule is placed in a launcher such that on extinction of the penultimate stage the altitude and the speed attained are sufficient to correspond to a stable orbit and the capsule is released before ignition of the final stage. 
<??>Application to the study of microgravity. 
<IMAGE>
Patent DE-69011609-T2 (DE)
Inventor: CRAWLEY GRAHAM CHARLES
IPC: A61P43/00
Filed: 1990-09-21
Granted: 1994-11-24
Abstract: The invention concerns a heterocyclic derivative of the formula I   <CHEM> wherein Q is an optionally substituted 6-membered monocyclic or 10-membered bicyclic heterocyclic moiety containing one or two nitrogen atoms;  X<1> is oxy, thio, sulphinyl, sulphonyl or imino;  Ar is phenylene which may optionally bear one or two substituents or Ar is an optionally substituted 6-membered heterocyclene moiety containing up to three nitrogen atoms;  R<1> is (1-6C)alkyl, (3-6C)alkenyl or (3-6C)alkynyl; and R<2> and R<3> together form a group of the formula -A<2>-X<2>-A<3>- which, together with the carbon atom to which A<2> and A<3> are attached, defines a ring having 4 to 7 ring atoms, wherein A<2> and A<3>, which may be the same or different, each is (1-4C)alkylene and X<2> is oxy, thio, sulphinyl, sulphonyl or imino;  or a pharmaceutically-acceptable salt thereof. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.
Patent DE-69016826-T2 (DE)
Inventor: MALEK LAWRENCE T
IPC: C12Q1/6865
Filed: 1990-05-08
Granted: 1995-06-08
Abstract: The invention relates to a method for the synthesis of ribonucleic acid starting from deoxyribonucleic acid in which a target sequence is present. Said DNA is treated with restriction enzyme(s) followed by strand separation. Subsequently one uses one nucleic acid primer containing a promoter sequence coupled to a nucleotide sequence which corresponds to a part of the target sequence. The invention further relates to a test kit for synthesizing RNA.
Patent DE-69021253-T2 (DE)
Inventor: ELLIOTT GARY KEITH
IPC: C04B35/80
Filed: 1990-03-06
Granted: 1996-01-04
Abstract: The invention relates to refractory supports such as kiln furniture used in the manufacture of ceramic articles and to a method of making them. The refractory support is a formed fired mass comprising bound alumina or aluminosilicate fibres with a filler and reactive binder, the binder containing both alumina and silica of colloidal particle size. Products can be made having the desired density, thermal mass and strength properties with reduced tendency to stick to the articles they support when the latter are being fired. A forming method to make the supports comprises preparing an aqueous slurry of the constituents, forming the slurry to a pre-form shape, e.g. by vacuum-forming, and pressing the preform followed by firing.
Patent DE-69024392-T2 (DE)
Inventor: MURPHY TIMOTHY F
IPC: C12P21/00
Filed: 1990-03-20
Granted: 1996-07-25
Abstract: A method of purifying an immunogenic outer membrane protein of H. flu. The steps comprising, formation of an insoluble fraction comprising the outer membrane protein associated with the peptidoglycan from the H. flu; digesting contaminated RNA from the insoluble fraction; separating the outer membrane protein from the insoluble fraction into the supernatant; and concentrating the solubilized outer membrane protein.
Patent DE-69029663-T2 (DE)
Inventor: VAN DE VEN WILLEM
IPC: C07K16/40
Filed: 1990-10-12
Granted: 1997-09-04
Abstract: The invention is based on the finding that furin belongs to a family of endoproteolytically active enzymes and relates to a process for the in vitro cleavage of a protein by treating the protein in the presence of Ca<2+> ions with furin or a furin-like enzyme, or an endoproteolytically active fragment, derivative or fusion protein of furin or furin-like enzyme. The invention can be used for the (micro)biological production of a protein by culturing genetically engineered cells expressing a pro-form of the protein as well as furin or a furin-like enzyme and isolating the protein formed.
Patent DE-69033776-T2 (DE)
Inventor: FETCENKO A
IPC: C22C19/03
Filed: 1990-11-20
Granted: 2001-11-22
Abstract: Disclosed is a reversible, electrochemical cell (10) having a high electrochemical activity, hydrogen storage negative electrode (12). The negative electrode is formed of a reversible, multicomponent, multiphase, electrochemical hydrogen storage alloy. The hydrogen storage alloy is capable of electrochemically charging and discharging hydrogen in alkaline aqueous media. In one preferred exemplification the hydrogen storage alloy is a member of the family of hydrogen storage alloys, derived from the V-Ti-Zr-Ni-Cr and V-Ti-Zr-Ni-Cr alloys in which the V, Ti, Zr, Ni and Cr are partially replaced by one or more modifiers, and the alloy has the composition: (Vy'-yNiyTix'-xZrxCrz)aM'bM''cM'''dM''''e, where x' is between 1.8 and 2.2, x is between 0 and 1.5, y' is between 3.6 and 4.4, y is between 0.6 and 3.5, z is between 0.00 and 1.44, a designates that the V-Ni-Ti-Zr-Cr component, as a group is from 70 to 100 atomic percent of the alloy, b, c, d, e, ..., are the coefficients on the modifiers, and M', M'', and M<i> are modifiers which may be individually or collectively up to 30 atomic percent of the total alloy. The modifiers, and M', M'', M<iii>, and M<iv> are modifiers which may be individually or collectively up to 30 atomic percent of the total alloy. The modifiers, M', M'', M<iii>, and M<iv> are chosen from Al, Mn, Mo, Cu, W, Fe, Co, Si, Sn, Zn and combinations thereof.
Patent DE-69103271-T2 (DE)
Inventor: GUEREMY CLAUDE
IPC: A61P25/28
Filed: 1991-05-31
Granted: 1994-12-22
Abstract: PCT No. PCT/FR91/00437 Sec. 371 Date Dec. 2, 1992 Sec. 102(e) Date Dec. 2, 1992 PCT Filed May 31, 1991 PCT Pub. No. WO91/18892 PCT Pub. Date Dec. 12, 1991.    <IMAGE>  (I)    Compounds of formula (I), in which R1 is a polyfluoralkoxy, R2 is a sulphur or nitrogen atom substituted by an alkyl radical or a sulfonyl or sulfinyl radical, R3 is a phenyl, benzoyl, -NR4R5 or piperidinyl-4radical substituted in position 1 by a phenylalkyl radical, R4 is an alkyl radical, R5 is a phenylalkyl radical, n is equal to 1, 2 or 3, m is equal to 0, 1, 2 or 3. The present invention also relates to the salts of said compounds, processes for the preparation of the latter and drugs containing them.
Patent DE-69111371-T2 (DE)
Inventor: FUKUDA TSUNEHIKO
IPC: C07K14/635
Filed: 1991-09-25
Granted: 1996-03-14
Abstract: Disclosed are (1) a DNA containing a synthetic gene for expression of human parathyroid hormone represented by the following DNA sequence: <IMAGE> (2) a method for producing the DNA described in (1), which comprises enzymatically ligating a plurality of oligodeoxynucleotides to one another to form the DNA and inserting the DNA into a vector if necessary, (3) a transformant transformed by the DNA described in (1), and (4) a method for producing human parathyroid hormone which comprises cultivating the transformant described in (3), accumulating human parathyroid hormone in a culture medium, and collecting the same, whereby hPTH can be allowed to express in large amounts in a system using E. coli as a host.
Patent DE-69122731-T2 (DE)
Inventor: ALBERTI GIULIO
IPC: C07F9/38
Filed: 1991-12-11
Granted: 1997-03-06
Abstract: A tetravalent metal diphosphonate-phosphite composition definable by the following general formula:    M(O3P-R-PO3)1-x(HPO3)2x   (I>  is described where:     M is a tetravalent metal;     x varies from 0.5 to 0.66; R is an organic radical of bivalent aromatic type, carrying side groups which increase its steric hindrance. The composition is in the form of a crystalline solid with a type  alpha  layered structure with the diphosphonic groups positioned to join said layers together by a covalent bond (pillared compounds). It has a B.E.T. surface area from 300 to 500 m<2>/g depending on the nature of R in formula (I), and a porosity in the micropore radius range of less than 20  ANGSTROM  (Angstrom), such micropores contributing to the extent of more than 95% of the total area for the most crystalline materials. <IMAGE>
Patent DE-69128893-T2 (DE)
Inventor: RAFIELD LORI
IPC: A61K35/12
Filed: 1991-10-31
Granted: 1998-09-10
Abstract: Retroviral vectors are disclosed which include an insertion site for genes of interest and are capable of expressing high levels of the protein derived from the genes of interest in a wide variety of transfected cell types. Also disclosed are retroviral vectors lacking a selectable marker, thus rendering them suitable for human gene therapy in the treatment of a variety of disease states without the co-expression of a marker product, such as an antibiotic. These retroviral vectors are especially suited for use in certain packaging cell lines.
Patent DE-69130705-T2 (DE)
Inventor: SCHEER DAVID
IPC: A61P31/12
Filed: 1991-03-28
Granted: 1999-06-10
Abstract: Compositions having significant activity as antiviral agent are disclosed containing, as an active component, a compound having the structural formula:  <IMAGE>  wherein R1 and R1' are the same or different and each is an alkyl group, a phenyl group or a substituted derivative of a phenyl group; wherein R2 and R2' are the same or different and each is hydrogen, an unbranched alkyl group, a halide or a group having the structure  <IMAGE>   wherein R is hydrogen, an alkoxide group, an alkyl group, or OH; wherein R3 and R3' are the same or different and each is hydrogen or an alkyl group; wherein X and X' are the same or different and each is a water soluble group having weak to intermediate ligand field strength; and Q- is a soluble, pharmaceutically acceptable negative ion. Methods of use of the inventive compositions are also disclosed.
Patent DE-69131399-T2 (DE)
Inventor: EL GAMAL ABBAS
IPC: H03K19/08
Filed: 1991-05-08
Granted: 1999-12-16
Abstract: An improved cell for use in a mask programmable gate array is disclosed herein. The preferred cell comprises two compute sections, each comprising two pairs of medium size P and N-channel transistors, two small N-channel transistors, and a single small P-channel transistor. Each cell also comprises a high efficiency drive section containing a single bipolar pull-up transistor, a large N-channel pull-down transistor, and a small P-channel transistor. By using this cell, an extremely high compute capability per die area is achieved.
Patent DE-69206180-T2 (DE)
Inventor: DINGLE TREVOR
IPC: B60P3/24
Filed: 1992-03-26
Granted: 1996-05-02
Abstract: A mobile road or rail tanker 10. The tanker 10 is formed of sheet aluminium which forms an outer shell 11. The shell 11 encloses a chamber 13 which is divided by a transverse wall 12. The wall 12 adjacent the shell 11 consists of an annealed heat treatable weldable aluminium alloy which is relatively soft and ductile so that weld material adjacent the wall 12 is stronger than the remainder of the wall 12. <IMAGE>
Patent DE-69206323-T2 (DE)
Inventor: SCHOUBYE PETER
IPC: C01B17/58
Filed: 1992-05-22
Granted: 1996-04-18
Abstract: Process for the regeneration of spent sulphuric acid from chemical processes, which process comprises the steps of evaporating and decomposing the spent sulphuric acid at a temperature of 400-800 DEG C with excess of air, to a gas mainly consisting of carbon dioxide, steam, nitrogen, oxygen, sulphur dioxide and sulphur trioxide together with minor amounts of ammonia, carbon monoxide, residual organic compounds and dust from solids in the spent acid; cooling the gas to 360-450 DEG C and oxidizing oxidizable components in the cooled gas by contact with an oxidation catalyst; cooling the oxidized gas to a temperature of 10-50 DEG C above the sulphuric acid dew point in the gas and condensing sulphuric acid formed in the cooled and oxidized gas. <IMAGE>
Patent DE-69210832-T2 (DE)
Inventor: STAFFORD RODNEY ARTHUR
IPC: G01V15/00
Filed: 1992-09-11
Granted: 1996-12-19
Abstract: PCT No. PCT/IE92/00009 Sec. 371 Date Jun. 22, 1994 Sec. 102(e) Date Mar. 11, 1994 PCT Filed Sep. 11, 1992 PCT Pub. No. WO93/05648 PCT Pub. Date Apr. 1, 1993.A bolus for administration to a ruminant animal and for retention in the rumen or reticulum of the animal, the bolus having an electronic identification device housed therein with an identification code encoded in the electronic device, and a permanent visual representation of the identification code on and/or within the bolus.
Patent DE-69222303-T2 (DE)
Inventor: MALFROY-CAMINE BERNARD
IPC: G01N33/569
Filed: 1992-04-30
Granted: 1998-01-22
Abstract: The subject application discloses methods and compositions for the targeted detection and/or inhibition of an intracellular protein in a cell by contacting the cell with a cationized antibody which reacts specifically with the intracellular protein. An example of an intracellular protein which can be inhibited in this manner is the Tat protein which is encoded by the HIV-1 virus.
Patent DE-69223231-T2 (DE)
Inventor: CAMPION TERESE A
IPC: A61F13/15
Filed: 1992-12-22
Granted: 1998-05-28
Abstract: An insertion device (10) for inserting material (13) into a body cavity is provided. An elongate, tubular holder (12), shaped for insertion into the body cavity, is adapted to hold the material to be inserted. The holder (12) has a material expulsion end portion (14) and a plunger (20), which is telescopically and slidably mounted in the holder, which is adapted to expel the material from the holder when pushed manually into the holder. The holder, and preferably the plunger as well, comprises an outer paper layer (28) and a polymer layer, preferably a cellophane layer (30), adhered to the paper layer on its outer surface, the layer having adequate water resistance to maintain its integrity during insertion into the body cavity. <IMAGE>
Patent DE-69224050-T2 (DE)
Inventor: GIRARD FRANCOIS
IPC: A43B13/00
Filed: 1992-09-26
Granted: 1998-05-28
Abstract: The sole (2) has an outer layer (7) which is made of supple material which adheres to the ground and resists abrasion. Its upper layer (8), directly under the foot (4), is assembled directly to the edge of the upper (3a) or to an inner sole. It is made of elastic material which absorbs shocks. An intermediate layer (9), fixed to the lower surface of the upper layer (9b) and the upper surface of the lower layer (9a), is made of material that is rigid in torsion and flexion. It distributes forces from the outer layer and transfers them through the upper layer.
Patent DE-69232944-T2 (DE)
Inventor: JARDIEU M
IPC: C07K19/00
Filed: 1992-08-14
Granted: 2003-12-24
Abstract: Two classes of polypeptides derived from human IgE are described. One class binds selectively to the high affinity IgE receptor on mast cells and basophils, but not to the low affinity IgE receptor on B-cells, monocytes, eosinophils and platelets. The other class binds to the low affinity receptor, but not the high affinity receptor. The differential binding polypeptides of this invention are useful in diagnostic procedures for IgE receptors or in the therapy of IgE-mediated disorders such as allergies. They also are useful in preparing antibodies capable of binding regions of IgE that participate in receptor binding.
Patent DE-69310170-T2 (DE)
Inventor: BASU RAJAT SUBHRA
IPC: C07C31/08
Filed: 1993-02-09
Granted: 1997-07-31
Abstract: Azeotrope like compositions comprising 1,1,2,3,3,-pentafluoropropane and methanol or ethanol and optionally nitromethane are stable and have utility as degreasing agents and as solvents in a variety of industrial cleaning applications including cold cleaning and defluxing of printed circuit boards and dry cleaning.
Patent DE-69316523-T2 (DE)
Inventor: DIIORIO MARK S
IPC: A61B5/05
Filed: 1993-10-23
Granted: 1998-09-10
Abstract: A biomagnetometer (10) includes a magnetic field sensor unit including a magnetic field pickup coil (12). A vessel (16) contains the sensor unit. The vessel (16) includes a flexible contact face (e.g., 240) with the magnetic field sensor unit mounted in the interior of the vessel (16) adjacent to the flexible contact face. Insulation at the flexible contact face (240) of the vessel (16) prevents excessive heat flow through the flexible contact face (240). Pickup units using this structure can be connected together into flexible or rigid arrays. In operation, the pickup coil is cooled to a temperature of less than its superconducting transition temperature. A detector (30) measures the magnitude of magnetic fields sensed by the sensor unit. <IMAGE>